Artrivet Forte
Injectable Solution

Phenylbutazone 200 mg
Dexamethasone 0.25 mg
Excipient q.s. 1 ml

DESCRIPTION: Analgesic, anti-inflammatory and anti-pyretic effect indicated in the treatment of locomotor system diseases.

INDICATIONS: Treatment of primary locomotor system diseases. Coadjutant treatment to the antibiotic therapy in infectious arthritis. Treatment of inflammatory processes in osteopathies, adenopathies, neuropathies, mastitis. To control congestive and painful symptoms associated to these processes.

TARGET SPECIES: Horses, dogs and cats.

ADMINISTRATION ROUTE: Intramuscular or intravenous.

Horses: Adult animals: 30 ml/day 1st day, 20 ml/day 2nd day, and subsequently 10 ml/day, during 4-6 days.
Foals: 10 ml/day 1st day and 5 ml subsequent 4-6 days.
Pets: 1 ml/15 kg b.w. per day, during 5 days

No withdrawal period. Do not administrate to horses if their meat will be used for human consumption.

3 years from production date.

COMMERCIAL PRESENTATION: 20 and 100 ml flasks.

pdfTechnical Data Artrivet_Forte.pdf